Impact of pre-eclampsia on renal outcome in sickle cell disease patients
© 2021 British Society for Haematology and John Wiley & Sons Ltd..
The long-term consequences of pre-eclampsia (PrE) for renal function have never been determined in patients with sickle cell disease (SCD). Between 2008 and 2015, we screened 306 pregnancies in women with SCD and identified 40 with PrE (13%). The control group consisted of 65 pregnant SCD patients without PrE. In multivariable analysis, PrE events were associated with an increase of 1 log of lactate dehydrogenase level (adjusted odds ratio, aOR = 3·83, P = 0·05), a decrease of 10 g/l of haemoglobin levels (aOR = 2·48, P = 0·006) and one or more vaso-occlusive crisis during pregnancy (aOR = 16·68, P = 0·002). Estimated glomerular filtration rate (eGFR) was similar in the two groups at steady state but was significantly lower in the PrE group after one year of follow-up and at last follow-up (130 vs 148 ml/min/1·73 m2 , P < 0·001 and 120 vs 130 ml/min/1·73 m2 , P < 0·001, respectively). In multivariable analysis, eGFR had returned to steady-state levels one year after pregnancy in patients without PrE but continued to decrease in patients with PrE (β = -18·15 ml/min/1·73 m2 , P < 0·001). This decline was more marked at the end of follow-up (β = -31·15 ml/min, P < 0·001). In conclusion, PrE episodes are associated with a significant risk of subsequent renal function decline in SCD patients.
Errataetall: |
CommentIn: Br J Haematol. 2021 Sep;194(6):947-949. - PMID 34121175 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:194 |
---|---|
Enthalten in: |
British journal of haematology - 194(2021), 6 vom: 16. Sept., Seite 1053-1062 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Boudhabhay, Idris [VerfasserIn] |
---|
Links: |
---|
Themen: |
Chronic kidney disease |
---|
Anmerkungen: |
Date Completed 16.12.2021 Date Revised 16.12.2021 published: Print-Electronic CommentIn: Br J Haematol. 2021 Sep;194(6):947-949. - PMID 34121175 Citation Status MEDLINE |
---|
doi: |
10.1111/bjh.17606 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM326795456 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM326795456 | ||
003 | DE-627 | ||
005 | 20231225195353.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/bjh.17606 |2 doi | |
028 | 5 | 2 | |a pubmed24n1089.xml |
035 | |a (DE-627)NLM326795456 | ||
035 | |a (NLM)34131893 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Boudhabhay, Idris |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of pre-eclampsia on renal outcome in sickle cell disease patients |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.12.2021 | ||
500 | |a Date Revised 16.12.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Br J Haematol. 2021 Sep;194(6):947-949. - PMID 34121175 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 British Society for Haematology and John Wiley & Sons Ltd. | ||
520 | |a The long-term consequences of pre-eclampsia (PrE) for renal function have never been determined in patients with sickle cell disease (SCD). Between 2008 and 2015, we screened 306 pregnancies in women with SCD and identified 40 with PrE (13%). The control group consisted of 65 pregnant SCD patients without PrE. In multivariable analysis, PrE events were associated with an increase of 1 log of lactate dehydrogenase level (adjusted odds ratio, aOR = 3·83, P = 0·05), a decrease of 10 g/l of haemoglobin levels (aOR = 2·48, P = 0·006) and one or more vaso-occlusive crisis during pregnancy (aOR = 16·68, P = 0·002). Estimated glomerular filtration rate (eGFR) was similar in the two groups at steady state but was significantly lower in the PrE group after one year of follow-up and at last follow-up (130 vs 148 ml/min/1·73 m2 , P < 0·001 and 120 vs 130 ml/min/1·73 m2 , P < 0·001, respectively). In multivariable analysis, eGFR had returned to steady-state levels one year after pregnancy in patients without PrE but continued to decrease in patients with PrE (β = -18·15 ml/min/1·73 m2 , P < 0·001). This decline was more marked at the end of follow-up (β = -31·15 ml/min, P < 0·001). In conclusion, PrE episodes are associated with a significant risk of subsequent renal function decline in SCD patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a chronic kidney disease | |
650 | 4 | |a pre-eclampsia | |
650 | 4 | |a risk factors | |
650 | 4 | |a sickle cell disease | |
650 | 4 | |a sickle cell nephropathy | |
700 | 1 | |a Boutin, Emmanuelle |e verfasserin |4 aut | |
700 | 1 | |a Bartolucci, Pablo |e verfasserin |4 aut | |
700 | 1 | |a Bornes, Marie-Isabelle |e verfasserin |4 aut | |
700 | 1 | |a Habibi, Anoosha |e verfasserin |4 aut | |
700 | 1 | |a Lionnet, François |e verfasserin |4 aut | |
700 | 1 | |a Hertig, Alexandre |e verfasserin |4 aut | |
700 | 1 | |a Grimbert, Philippe |e verfasserin |4 aut | |
700 | 1 | |a Stehlé, Thomas |e verfasserin |4 aut | |
700 | 1 | |a El Karoui, Khalil |e verfasserin |4 aut | |
700 | 1 | |a Sahali, Dil |e verfasserin |4 aut | |
700 | 1 | |a Fois, Elena |e verfasserin |4 aut | |
700 | 1 | |a Rémy, Philippe |e verfasserin |4 aut | |
700 | 1 | |a Galacteros, Frédéric |e verfasserin |4 aut | |
700 | 1 | |a Haddad, Bassam |e verfasserin |4 aut | |
700 | 1 | |a Canoui-Poitrine, Florence |e verfasserin |4 aut | |
700 | 1 | |a Lecarpentier, Edouard |e verfasserin |4 aut | |
700 | 1 | |a Audard, Vincent |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t British journal of haematology |d 1955 |g 194(2021), 6 vom: 16. Sept., Seite 1053-1062 |w (DE-627)NLM000000396 |x 1365-2141 |7 nnns |
773 | 1 | 8 | |g volume:194 |g year:2021 |g number:6 |g day:16 |g month:09 |g pages:1053-1062 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/bjh.17606 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 194 |j 2021 |e 6 |b 16 |c 09 |h 1053-1062 |